Dihydroergotamine

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

2 posts / 0 new
Last post
Meg Jennings
Meg Jennings's picture
Offline
Last seen: 3 weeks 21 hours ago
Joined: 08/09/2023 - 15:44
Dihydroergotamine

For intermittent dosing of IV DHE for pediatric patients with migraines. Is there evidence to support dilution of the medication (stability). Have your team's extended the duration of administration beyond 2-3 minutes.

What evidence sources did you utilize for stability to dilute and extend the duration?

Lexicomp:
IV: Children ≥6 years and Adolescents: May be administered undiluted slowly over 2 to 3 minutes; or diluted and infused over 60 minutes (Ref). Test doses have been administered over 5 minutes

Tags: